Outcome after radical prostatectomy in young men with or without a family history of prostate cancer

Urology

Volumn 67, Issue 5, 2006, Pages 1028-1032

  Rouprêt, Morgan ^a,b,c   Fromont, Gaëlle ^b,c   Bitker, Marc Olivier ^a   Gattegno, Bernard ^a   Vallancien, Guy ^b,c   Cussenot, Olivier ^a,b,c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b INSTITUT MUTUALISTE MONTSOURIS   (France)

^c HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; ETHNOLOGY; FAMILIAL CANCER; FAMILY HISTORY; FOLLOW UP; GLEASON SCORE; HUMAN; INFORMATION PROCESSING; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; BLOOD; CANCER STAGING; GENETIC PREDISPOSITION; GENETICS; LAPAROSCOPY; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; RETROSPECTIVE STUDY; SURVIVAL;

ADULT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33646847121     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.11.035     Document Type: Article

References (30)

1. Boyle P., Severi G., and Giles G.G. The epidemiology of prostate cancer. Urol Clin North Am 30 (2003) 209-217
2. Oliver S.E., May M.T., and Gunnell D. International trends in prostate-cancer mortality in the "PSA era". Int J Cancer 92 (2001) 893-898
3. Smith C.V., Bauer J.J., Connelly R.R., et al. Prostate cancer in men age 50 years or younger. a review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database. J Urol 164 (2000) 1964-1967
4. Aprikian A.G., Zhang Z.F., and Fair W.R. Prostate adenocarcinoma in men younger than 50 years. a retrospective review of 151 patients. Cancer 74 (1994) 1768-1777
5. Sacco E., Prayer-Galetti T., Pinto F., et al. Familial and hereditary prostate cancer by definition in an Italian surgical series. clinical features and outcome. Eur Urol 47 (2005) 761-768
6. Azzouzi A.R., Valeri A., Cormier L., et al. Familial prostate cancer cases before and after radical prostatectomy do not show any aggressiveness compared with sporadic cases. Urology 61 (2003) 1193-1197
7. Bill-Axelson A., Holmberg L., Ruutu M., et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352 (2005) 1977-1984
8. Harrison G.S. The prognosis of prostatic cancer in the younger man. Br J Urol 55 (1983) 315-320
9. Bratt O., Kristoffersson U., Olsson H., et al. Clinical course of early onset prostate cancer with special reference to family history as a prognostic factor. Eur Urol 34 (1998) 19-24
10. Khan M.A., Han M., Partin A.W., et al. Long-term cancer control of radical prostatectomy in men younger than 50 years of age. update 2003. Urology 62 (2003) 86-92
11. Merrill R.M., and Bird J.S. Effect of young age on prostate cancer survival. a population-based assessment (United States). Cancer Causes Control 13 (2002) 435-443
12. Freedland S.J., Presti Jr. J.C., Kane C.J., et al. Do younger men have better biochemical outcomes after radical prostatectomy?. Urology 63 (2004) 518-522
13. Catalona W.J., Carvalhal G.F., Mager D.E., et al. Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol 162 (1999) 433-438
14. Guillonneau B., el-Fettouh H., Baumert H., et al. Laparoscopic radical prostatectomy. oncological evaluation after 1,000 cases at Montsouris Institute. J Urol 169 (2003) 1261-1266
15. Nehra A., Grantmyre J., Nadel A., et al. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy. J Urol 173 (2005) 2067-2071
16. Steineck G., Helgesen F., Adolfsson J., et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 347 (2002) 790-796
17. Twiss C., Slova D., and Lepor H. Outcomes for men younger than 50 years undergoing radical prostatectomy. Urology 66 (2005) 141-146
18. Valeri A., Cormier L., Moineau M.P., et al. Targeted screening for prostate cancer in high risk families. early onset is a significant risk factor for disease in first degree relatives. J Urol 168 (2002) 483-487
19. Carter B.S., Beaty T.H., Steinberg G.D., et al. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 89 (1992) 3367-3371
20. Cotter M.P., Gern R.W., Ho G.Y., et al. Role of family history and ethnicity on the mode and age of prostate cancer presentation. Prostate 50 (2002) 216-221
21. Cussenot O., and Valeri A. Heterogeneity in genetic susceptibility to prostate cancer. Eur J Intern Med 12 (2001) 11-16
22. Valeri A., Azzouzi R., Drelon E., et al. Early-onset hereditary prostate cancer is not associated with specific clinical and biological features. Prostate 45 (2000) 66-71
23. D'Amico A.V., Renshaw A.A., Cote K., et al. Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease. J Clin Oncol 22 (2004) 3726-3732
24. Diblasio C.J., and Kattan M.W. Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer. Urology 62 suppl 1 (2003) 9-18
25. Johansson J.E., Andren O., Andersson S.O., et al. Natural history of early, localized prostate cancer. JAMA 291 (2004) 2713-2719
26. Gayther S.A., de Foy K.A., Harrington P., et al. the Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. Cancer Res 60 (2000) 4513-4518
27. Ravery V., Goldblatt L., Royer B., et al. Extensive biopsy protocol improves the detection rate of prostate cancer. J Urol 164 (2000) 393-396
28. Valeri A., Fournier G., Morin V., et al. Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives. Int J Cancer 86 (2000) 883-887
29. Krumholtz J.S., Carvalhal G.F., Ramos C.G., et al. Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features. Urology 60 (2002) 469-474
30. Whittemore A.S., Cirillo P.M., Feldman D., et al. Prostate specific antigen levels in young adulthood predict prostate cancer risk. results from a cohort of black and white Americans. J Urol 174 (2005) 872-876